Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial

BACKGROUND: With the help of a measurement feedback system, the treatment strategy for individual patients with rheumatoid arthritis (RA) can be adjusted to achieve optimal control of disease activity. OBJECTIVE: To study whether a measurement feedback system is effective in reducing disease activity in patients with RA. METHODS: Forty eight rheumatologists and 264 patients participated in a controlled clinical trial. A three month control period was followed by a 12 month period, where feedback on disease activity, disability, and damage was provided to the rheumatologist. The primary outcome measure was the rheumatoid arthritis disease activity index (RADAI). RESULTS: The feedback system was used for 142/228 (62%) patients. Disease modifying antirheumatic drug changes occurred in 69/169 (41%) patients. In patients with high disease activity and feedback use (n=70), the RADAI decreased in the feedback period by -0.27 points per 30 days (p<0.05), as compared with the control period. Patients for whom the feedback system was used had a better outcome than non-users. CONCLUSION: Much more training on the use of a feedback system and outcome measures, as well as the inclusion of explicit treatment guidelines will be necessary to increase the clinical use of measurement feedback and, possibly, to reduce disease activity for a larger number of patients with RA.     

Brief scales for measurement of functional social support and psychological resources in French-speaking adults

OBJECTIVES: Psychological resources and social support are important determinants of health, but brief and validated scales measuring these dimensions in French are lacking. METHODS: Instruments measuring self-esteem and mastery, and affective and confident social support were administered by mail to 1257 university students. Factor analysis, internal consistency statistics, and correlations with related variables were used to derive abbreviated scales and confirm their validity. RESULTS: Factor analysis and item reduction yielded four brief scales: mastery (4 items), self-esteem (4 items), affective social support (2 items), and problem-solving social support (4 items). All four scales had few missing items and adequate internal consistency (Cronbach's alpha > 0.70). All scores were associated with self-reported general health, and with visits to mental health specialists. Scores of self-esteem and mastery were also associated with physician visits (inversely), and confidence in finishing studies and finding a job. Scores of affective and confident social support correlated with the intensity of social activities and the number of people the respondent could count on. CONCLUSIONS: The abbreviated scales retained adequate psychometric properties and may be usefully applied in health research among similar French-speaking populations.     

Effect of visual stimulation on blood oxygenation in the optic nerve head of miniature pigs: a pilot study

BACKGROUND: Visual stimulation is increasingly used to investigate the coupling between neuronal activity, blood flow and metabolism in the neural tissue of the ocular fundus. In an attempt to clarify whether the oxygen metabolism is involved in this coupling, we investigated the changes in the partial pressure of oxygen of venous blood (pO (2,blood)) in the optic nerve head of pigs in response to two different visual stimuli. MATERIALS AND METHODS: In 3 miniature pigs, the pO (2,blood) was measured in the optic disk rim using the technique of phosphorescence quenching by oxygen. This parameter was recorded every 8 seconds during a dark-to-light transition and during diffuse luminance flicker (field of 30 degrees centered at the optic disk, temporal frequencies of 2 to 80 Hz). RESULTS: The venous pO (2,blood) level (mean +/- standard deviation) did not change between dark- and light-adapted conditions (26.2 +/- 5.3 and 26.0 +/- 6.2 mm Hg, respectively), nor did we observe any transient change of pO (2,blood) during the light adaptation phase. On the other hand, the venous pO (2,blood) increased, on average, relative to its level during continuous light conditions (24.5 +/- 1.9 mm Hg) by at least 6 % for all flickering frequencies, with a maximum response of 14 % at 15 Hz. CONCLUSIONS: The phosphorescence quenching technique can reveal changes in venous pO (2,blood) induced by visual stimulation. Our results show that the pO (2,blood) in the optic nerve head of miniature pigs does not change with the light adaptation state of the retina, but increases during flicker stimulation with a band-pass type response. The previously reported increase of the ONH blood flow in response to flicker stimulation could lead to this increase of pO (2,blood).     

Blood flow in the human iris measured by laser Doppler flowmetry

A new instrument based on laser Doppler flowmetry (LDF) has been developed to determine noninvasively the relative flux of red blood cells (RBCs) through the microcirculatory network of the iris of the human eye. The probing laser, photodetector, and target fixation devices required by this method were adapted to a slit lamp. Electronic processing and computer analysis of the Doppler signal allow determination of relative velocity, number, and flux of RBCs in the iris, as well as the pulsatility of these flow parameters during the heart cycle. Based on measurements in one eye of eight normal volunteers, the sensitivity of the technique, i.e., the minimum change detectable at the P < 0.05 level, was 4% for the flux. The decrease in blood flow in response to decreases of the ocular perfusion pressure demonstrates the capability of the technique to detect flow changes and its suitability for investigating the physiology and the pharmacology of iris circulation.     

Nonresponse bias in a survey of patient perceptions of hospital care

BACKGROUND: Incomplete participation is of particular concern for surveys of patient perceptions of care because patients who have negative opinions may be least likely to participate. OBJECTIVE: We sought to examine indirect evidence of nonresponse bias. DESIGN: We re-analyzed data from a cross-sectional patient survey. SUBJECTS: Our subjects were patients discharged from a Swiss hospital (n = 2156). MEASURES: We measured the following: (1) an observed problem score, based on 15 key items of the Picker Patient Experience questionnaire, (2) a predicted problem score, and (3) a participation propensity score. The latter scores were computed for all eligible patients, including those who did not return the survey, from routinely available baseline data. RESULTS: The participation rate was 70% (n = 1518), and the mean problem score was 29.9 (SD 23.8). Early respondents reported significantly fewer problems than late respondents (28.6 versus 32.9, P = 0.001). Participation propensity scores were progressively lower in early respondents (mean 74.2), late respondents (70.7), and nonrespondents (63.9, P < 0.001); the pattern was similar for predicted problem scores (early respondents: 29.5; late respondents: 30.5; nonrespondents: 33.4, P < 0.001). The propensity to participate was negatively associated with the problem score (Pearson r = -0.19). Finally, predictors of participation were similar to predictors of problem scores. CONCLUSIONS: The tendency to participate in the survey was negatively associated with the report of problems during hospitalization. Nevertheless, increasing participation from 30% to 70% had only a modest influence on the final conclusions of the survey.     

Determinants of third dose of diphtheria–tetanus–pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study

Objective  In Pakistan, a high proportion of children fail to complete third dose of diphtheria-tetanus-pertussis (DTP3) after having received the first dose (DTP1). A cohort study was conducted to identify the factors predicting three doses of diphtheria–tetanus–pertussis (DTP3) completion among children who have received DTP1 at six centres of Expanded Programme on Immunization (EPI) in rural Pakistan.
Method  We analyzed a cohort of mother–child pairs enrolled at DTP1 between November 2005 and May 2006 in the standard care group of a larger randomized controlled trial. Data were collected from mothers on a structured questionnaire at enrolment, and each child was followed up at clinic visits for 90 days to record dates of DTP2 and DTP3. Multivariable log-binomial regression analysis was performed to identify the independent predictors of DTP3 completion.
Results  Only 39% (149/378) of enrolled children completed DTP3 during the follow-up period. After adjusting for the centre of enrolment in multivariable analysis, DTP3 completion was higher among children who were ≤60 days old at enrolment [adjusted risk ratio (Adj. RR) 1.39, 95% confidence interval (CI): 1.06–1.82], who were living in a household with monthly household income >Rs. 3000 (US$ 50) (Adj. RR 1.76, 95% CI: 1.16–2.65), and who were living ≤10 min away from EPI centre (Adj. RR 1.31, 95% CI: 1.04–1.66).
Conclusions  Interventions targeting childhood immunization dropouts should focus on bringing more children to EPI centres on-time for initial immunization. Relocation of existing EPI centres and creation of new EPI centres at appropriate locations may decrease the travel time to the EPI centres and result in fewer immunization dropouts.     

Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study

OBJECTIVE: Limited data have been published on tolerance to and efficacy of classic or biologic disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (RA). The goal of the present study was to evaluate the tolerance to and effectiveness of anti-tumor necrosis factor (anti-TNF) agents in elderly patients (> or =65 years old) with RA (ERA) in comparison with younger patients (YRA). METHODS: The Swiss Clinical Quality Management program for RA is a longitudinal population-based cohort. All patients who had received at least 1 dose of anti-TNF agents between January 1997 and November 2005 were included and categorized according to their age. Tolerance was assessed by analyzing discontinuation rates of anti-TNF agents. Effectiveness of these agents was assessed by analyzing RA disease activity (Disease Activity Score in 28 joints [DAS28]) and functional disability (Health Assessment Questionnaire [HAQ]) after anti-TNF initiation. RESULTS: Among 1,571 patients with RA treated with anti-TNF agents, 344 were > or =65 years of age at treatment initiation. Drug discontinuation rates (median time 3 years) and mean change in DAS28 scores at 2 years (-0.65 versus -0.58) were identical in ERA and YRA. However, HAQ score improved significantly less in ERA (-0.02) than in YRA (-0.1) and a subsequent analysis revealed that this finding was essentially due to patients >75 years of age. CONCLUSION: Age in itself should not interfere with the decision to treat elderly patients with RA with anti-TNF agents. In a subset of patients ages >75 years, no functional improvement according to HAQ should be expected despite improvements in disease activity.